Tin tức & Cập nhật
Xem bài viết Thần kinh
Xem
Chỉ hiển thị Multimedia

How does baricitinib compare in RA patients at risk of VTE?
03 Jul 2026
bởiStephen Padilla
Treatment with baricitinib misses the noninferiority mark against tumour necrosis factor inhibitors (TNFi) in active rheumatoid arthritis (RA) patients at risk for venous thromboembolism (VTE) with high baseline disease activity, reports a study.








